| 1 |
Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice |
|
|
| Zackary A. Cope, Johnny A. Kenton, Arpi Minassian, Maureen V. Martin, William Perry, Christoffer Bundgaard, Jørn Arnt, Jordy van Enkhuizen, Mark A. Geyer, Jared W. Young |
|
| Behavioural Brain Research. 2021; 405: 113167 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Recent advances in the development of asenapine formulations |
|
|
| Akhil Suresh, Reema Narayan, Usha Y Nayak |
|
| Expert Opinion on Drug Delivery. 2020; 17(10): 1377 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Controlled Parenteral Formulations: An Efficacious and Favourable Way to Deliver the Anti-psychotic Drugs |
|
|
| Harshita Gupta, Rutu Panchal, Niyati Acharya, Priti Jignesh Mehta |
|
| Current Psychiatry Research and Reviews. 2020; 16(1): 42 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Atypical antipsychotics: trends in analysis and sample preparation of various biological samples |
|
|
| Domniki Fragou, Spyridoula Dotsika, Parthena Sarafidou, Victoria Samanidou, Samuel Njau, Leda Kovatsi |
|
| Bioanalysis. 2012; 4(8): 961-980 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Therapeutic drug monitoring of common antipsychotics |
|
|
| Patteet, L. and Morrens, M. and Maudens, K.E. and Niemegeers, P. and Sabbe, B. and Neels, H. |
|
| Therapeutic Drug Monitoring. 2012; 34(6): 629-651 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Asenapina — nowy atypowy lek przeciwpsychotyczny Asenapine — a new atypical antipsychotic |
|
|
| A Wysokiński, I Kłoszewska |
|
| Psychiatry. 2012; 9(1): 27-35 |
|
| [HTML Full text] [Google Scholar] |
|
| 7 |
Therapeutic Drug Monitoring of Common Antipsychotics |
|
|
| Lisbeth Patteet,Manuel Morrens,Kristof E. Maudens,Peter Niemegeers,Bernard Sabbe,Hugo Neels |
|
| Therapeutic Drug Monitoring. 2012; 34(6): 629 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management |
|
|
| Levine M, Ruha AM. |
|
| CNS Drugs. 2012 Jul 1;26(7):601-11. 2012; 26(7): 601-611 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
